0
     

Report Added
Report already added
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

Report Scope:

This report examines the current and future market potential of the U.S. biodefense-related rapid pathogen identification and treatment market. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement, drivers and restraints, and it identifies opportunities and trends in market growth. The report also covers market projections to 2026.

For market estimates, data is provided for the following year 2019, 2020, 2021 and 2026. Year 2020 is the base year, and forecast through year 2026.

Report Includes:

- 79 tables
- An overview of the U.S. market for biodefense-related rapid pathogen identification and treatments
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Discussion of key market dynamics (DROs), technological advancements, and regulatory landscape in the context of biodefense-related rapid pathogens
- Evaluation and forecast the biodefense-related pathogen detection products market size in dollar value terms, and corresponding market share analysis by type, testing method, device type, technology, application etc.
- Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for infectious agents with detection, vaccine and treatment information, ongoing R&D activities, and clinical trials etc.
- Review of the infectious agents including smallpox, anthrax, plague and tularaemia, as well as coverage of potentially harmful chemical toxins that are used in biological warfare situations including sarin gas, ricin and botulinum
- Impact of COVID-19 on bioinformatics research and new developments relate to biodefense-related diagnostic tools
- Review of patents issued for rapid pathogen identification and industry specific new developments
- Insight into the recent industry strategies and competitive landscape of the major players operating within the global market, along with their company share analysis
- Profile descriptions of the leading industry players, including ANP Technologies, Biomerieux, Haztech, Menon Biosensors, Merck, Thermo Fisher Scientific and GlaxoSmithKline

Summary:

Despite the renewal of the 1975 Biological Weapons Commission in 2009, the U.S. Department of State estimates that more than a dozen countries are developing biological weapons. Of significant concern is the possibility that domestic or international terrorist groups could acquire or create biological weapons and use them against unprotected civilian or military targets. The anthrax letter attacks in 2001, which resulted in the infection of 23 Americans and the death of five, heightened Americans’ sense of vulnerability. Since 2001, the U.S. government has spent or allocated more than $60 billion toward biological weapons research, which has included developing and distributing air sensors, educating
doctors about the symptoms of bioterror pathogens and distributing medical supplies for biodefense to hospitals.

Biological substances that can be weaponized for either civilian or military destruction are a biodefense related issue. Identifying these substances accurately and rapidly is at the heart of this report. Additionally, treatment methods such as vaccines and oral pharmaceuticals will be discussed.

Detection

Pathogenic agents can be viruses, bacteria, fungi, protozoa, parasites or manufactured toxins. They can cause diseases in plants, animals and humans. Pathogens that are harmful to animals and plants are not covered in this report unless they pose eminent danger, as did brucellosis or the plague, to humans through consumption. The infectious agents discussed in this report include smallpox, anthrax, plague and tularemia. Another area of pathogen identification includes potentially harmful chemical toxins that are used in biological warfare situations, such as ricin and botulinum.

Within the military and civilian arenas, the report covers products and strategies that identify pathogens introduced in the air, water and by other means. The report also reviews global metrics for known diseases, and it forecasts trends and indicators for potential weaponization of these diseases. The process of rapid identification of potentially harmful pathogens falls into two categories: specimen testing (e.g., immunoassay) and sensors (e.g., airborne pathogens). Both identification methods are discussed in this report, and potential markets for products are projected through 2026.

The most frequently available detection tests are those aimed at detecting anthrax, smallpox and tularemia. Some assays can detect more than one pathogen simultaneously. The most common combination tests include anthrax, smallpox, plague, tularemia, botulism and Staphylococcal enterotoxin B (SEB). The development of viral tests for pandemic influenza and COVID-19 is ongoing, but as with treatment, the detection of viruses is more complicated than that of bacterial pathogens.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update
Information Sources
Methodology
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Detection
Handheld Devices
Factors Contributing to the Market for Biodefense-Related Pathogen Identification
Highlights of the U.S. Market for Biodefense-Related Rapid Pathogen Identification
Treatment
Chapter 3 Industry Overview
Introduction
Delivery and Detection
Methods of Dissemination
Potential Biological Pathogens
Rapid Identification Products
Sensing Technology
Detect-to-Warn Systems
Treatment
Vaccines
Pharmaceuticals Used to Treat Biodefense-Related Pathogens
Planning and Response to Bioterrorism Event
Microbial Forensics
Role of Government, Universities and Private Funding in Product Development
Funding Options
Chapter 4 Overview of Infectious Agents
Introduction
Categories of Bacterial Agents
Category A Bacterial Agents
Category A Viral Agents
Category B Bacterial Agents
Category B Toxins
Chapter 5 Biodefense-Related Pathogen Detection Devices
Pathogen ID Devices by Testing Method
Types of Devices
Diagnostic Tools
Mass Spectrometry
PCR
Immunological Analysis
Biological Sensors
Biodefense Biosensor Market
Chapter 6 Patents and Market Dynamics
Introduction
Patents on Rapid Pathogen Identification: 2019-2021
Pharmaceutical Market Opportunities/Challenges
Vaccine Market Opportunities/Challenges
Device Market Opportunities/Challenges
Challenges
Opportunities
Chapter 7 Company Profiles
Diagnostic Products
ANP TECHNOLOGIES
ALPHA DIAGNOSTIC INTERNATIONAL
BATTELLE
BIOMERIEUX INC.
BIOSEARCH TECHNOLOGIES
BIOTECH INTERNATIONAL
BRUKER DETECTION
CORGENIX MEDICAL CORP.
DIATHERIX
ELECTRONIC SENSOR TECHNOLOGY INC.
HAZTECH SYSTEMS
INBIOS INTERNATIONAL INC.
INTEGRATED NANO-TECHNOLOGIES
MENON BIOSENSORS INC.
MESO SCALE DEFENSE
NANOLOGIX
NEW HORIZON DIAGNOSTIC CORP.
POSITIVE ID CORP.
THERMO FISHER SCIENTIFIC INC.
Vaccines
BAVARIAN NORDIC A/S
CRUCELL HOLLAND B.V.
EMERGENT BIOSOLUTIONS
INOVIO PHARMCEUTICALS
NOVAVAX
PHARMATHENE INC.
SOLIGENIX
TAPIMMUNE
Pharmaceuticals
GLAXOSMITHKLINE
MERCK
SAREPTA THERAPEUTICS
SIGA TECHNOLOGIES
National Laboratories
LAWRENCE LIVERMORE NATIONAL LABORATORIES
SABIN VACCINE INSTITUTE
Chapter 8 Appendix: List of Acronyms

List of Tables
Summary Table : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment, by Type, Through 2026
Table 1 : Class A: Bioterrorism Agents
Table 2 : Class A: Pathogen Identification, by Transmission Method
Table 3 : Class B: Bioterrorism Agents/Diseases
Table 4 : Class B: Pathogen Identification, by Transmission Method
Table 5 : Class C: Bioterrorism Agents/Diseases
Table 6 : Additional Emerging Infectious Disease Pathogens
Table 7 : Class C: Pathogen Identification, by Transmission Method
Table 8 : Limitations of Some Common Analysis Methods
Table 9 : Characteristics of Biosensors
Table 10 : Detect-to-Warn Monitoring Systems
Table 11 : Pathogen Vaccines, 2019
Table 12 : Pharmaceuticals Used to Treat Biodefense-Related Pathogens, 2019
Table 13 : Industrial R&D Expenditures in Life Science Technologies, 2017-2019
Table 14 : Biodefense-Related Pathogen Identification with Test and Test Result Time
Table 15 : Rapid Tests Used to Detect Anthrax B. anthracis Bacteria
Table 16 : Rapid Tests Used to Detect Yersinia pestis Bacteria
Table 17 : Rapid Tests Used to Detect Francisella tularensis Bacteria
Table 18 : Rapid Tests Used to Detect Smallpox
Table 19 : Rapid Tests Used to Detect Pandemic Influenza
Table 20 : Distribution of COVID-19 Clinical Symptoms
Table 21 : Rapid Tests Used to Detect COVID-19
Table 22 : Rapid Tests Used to Detect Ebola Hemorrhagic Fever
Table 23 : Vaccines in Clinical Trials for Ebola Hemorrhagic Fever
Table 24 : Pharmaceuticals in Clinical Trials for Ebola Hemorrhagic Fever
Table 25 : Rapid Test to Detect Marburg Hemorrhagic Fever
Table 26 : Rapid Tests Used to Detect Brucella
Table 27 : Rapid Tests Used to Detect Salmonella
Table 28 : Rapid Tests Used to Detect E. Coli Bacteria
Table 29 : Rapid Tests Used to Detect Burkholderia mallei Bacteria
Table 30 : Rapid Test Used to Detect Burkholderia pseudomallei Bacteria
Table 31 : Rapid Tests Used to Detect Chlamydia psittaci bacteria
Table 32 : Rapid Tests Used to Detect Coxiella burnetiid Bacteria
Table 33 : Rapid Tests Used to Detect Staphylococcal Enterotoxin B
Table 34 : Method to Detect Salmonella typhi bacteria
Table 35 : Vaccines Used to Prevent Typhoid Infections
Table 36 : Rapid Tests Used to Detect Vibro cholerae Bacteria
Table 37 : Methods Used to Detect Cryptosporidium
Table 38 : Rapid Tests Used to Detect Viral Encephalitis
Table 39 : Rapid Tests to Diagnose Ricin Poisoning
Table 40 : Rapid Tests Used to Detect Botulism Poisoning
Table 41 : Vaccines to Treat Botulism
Table 42 : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment, by Type, Through 2026
Table 43 : U.S. Market for Biodefense-Related Detection Devices, by Testing Method, Through 2026
Table 44 : U.S. Market for Biodefense-Related Detection Devices, by Device Type, Through 2026
Table 45 : U.S. Market for Biodefense-Related Mass Spectrometry Devices, Through 2026
Table 46 : U.S. Market for Biodefense-Related PCR Devices, Through 2026
Table 47 : U.S. Market for Biodefense-Related PCR Devices, by Technology, Through 2026
Table 48 : U.S. Market for Biodefense-Related Immunological Devices, Through 2026
Table 49 : U.S. Market for Biodefense-Related Biological Sensors, Through 2026
Table 50 : U.S. Patents on Rapid Pathogen Identification Technologies, 2019-2021
Table 51 : ANP Technologies: Diagnostic Products
Table 52 : Alpha Diagnostic International: Diagnostic Products
Table 53 : Battelle: Diagnostic Products
Table 54 : Biomerieux: Biodefense-Related Diagnostic Products
Table 55 : Biosearch Technologies: Diagnostic Products
Table 56 : Biotech International: Biodefense-Related Diagnostic Product
Table 57 : Bruker: Biodefense-Related Diagnostic Products
Table 58 : Corgenix: Diagnostic Products
Table 59 : Diatherix: Diagnostic Products
Table 60 : Electronic Sensor Technology: Diagnostic Products
Table 61 : Haztech: Biodefense-Related Products
Table 62 : Inbios: Diagnostics Products
Table 63 : Integrated Nano-Technologies: Diagnostics Products
Table 64 : Menon Biosensors: Diagnostic Products
Table 65 : Meso Scale Defense: Diagnostics Products
Table 66 : Nanologix: Diagnostics Products
Table 67 : New Horizon: Diagnostics Products
Table 68 : Positive ID: Diagnostics Products
Table 69 : Thermo Fisher Scientific: Products and Services
Table 70 : Bavarian Nordic: Biodefense Vaccine Products
Table 71 : Emergent Biosolutions: Vaccine Products
Table 72 : Inovio Pharmaceuticals: Vaccine Products
Table 73 : Novavax: Vaccine Products
Table 74 : Pharmathene: Vaccine Products
Table 75 : GlaxoSmithKline: Pharmaceutical Products
Table 76 : Merck: Biodefense-Related Pharmaceutical Products
Table 77 : Siga: Biodefense-Related Product
Table 78 : Acronyms Used in the U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment

List of Figures
Summary Figure : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment, by Type, 2019-2026
Figure 1 : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment
Figure 2 : U.S. Market Shares of Biodefense-Related Rapid Pathogen Detection Devices, by Testing Method, 2020 and 2026
Figure 3 : U.S. Market Shares of Biodefense-Related Rapid Pathogen Detection Devices, by Device Type, 2020 and 2026
Figure 4 : Thermo Fisher Scientific: Annual Revenue, 2018-2020
Figure 5 : Thermo Fisher Scientific: Revenue Share, by Product Category, 2020

Report Title: The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW